您的购物车当前为空
别名 Portamycin
Streptolydigin inhibits RNA synthesis by binding to RNA polymerase and does not inhibit eukaryotic RNA polymerases. Streptolydigin is a 3-acetyltetramic acid antibiotic and a potent bacterial RNA polymerase inhibitor (Ki: 18 μM and a Kd: 15 μM).

Streptolydigin inhibits RNA synthesis by binding to RNA polymerase and does not inhibit eukaryotic RNA polymerases. Streptolydigin is a 3-acetyltetramic acid antibiotic and a potent bacterial RNA polymerase inhibitor (Ki: 18 μM and a Kd: 15 μM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | 待询 | 3-6月 | |
| 50 mg | 待询 | 3-6月 | |
| 100 mg | 待询 | 3-6月 |
| 产品描述 | Streptolydigin inhibits RNA synthesis by binding to RNA polymerase and does not inhibit eukaryotic RNA polymerases. Streptolydigin is a 3-acetyltetramic acid antibiotic and a potent bacterial RNA polymerase inhibitor (Ki: 18 μM and a Kd: 15 μM). |
| 靶点活性 | RNA polymerase (bacterial):(ki)18 μM |
| 体外活性 | Streptolydigin inhibits initiation, elongation, and pyrophosphorolysis by bacterial RNA polymerase. Streptolydigin inhibits T. thermophilus RNA polymerase (a Ki: 1.8 μM). Binding of Streptolydigin to RNA polymerase strictly depends on a noncatalytic magnesium ion which is likely chelated by the aspartate of the bridge helix of the active center. Streptolydigin interacts with three structural elements within RNAP: the Stl pocket, the bridge helix, and the trigger-loop region. The Streptolydigin streptolol moiety interacts with the Streptolydigin pocket and bridge helix, and the Streptolydigin tetramic-acid moiety interacts with the trigger-loop region [1][3]. |
| 别名 | Portamycin |
| 分子量 | 600.70 |
| 分子式 | C32H44N2O9 |
| CAS No. | 7229-50-7 |
| Smiles | C[C@@]12[C@]3(CO3)C=C[C@@H](O1)[C@H](C)[C@@]([C@@H](/C=C(/C=C/C(/O)=C/4\C(=O)N([C@@]([C@@H](C(NC)=O)C)(C4=O)[H])[C@]5(O[C@@H](C)[C@@H](O)CC5)[H])\C)C)(O2)[H] |
| 密度 | 1.1852 g/cm3 (Estimated) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多